A Randomized Phase 2 Study of Sapacitabine, An Oral Nucleoside Analogue, in Older Patients with Myelodysplastic Syndrome (MDS) Refractory to Hypomethylating Agents.
Year: 2009
Type: article
Source: Blood
Institutions: The University of Texas MD Anderson Cancer Center, Abramson Cancer Center, University of Pennsylvania, Rush University Medical Center, University of Nebraska Medical Center, Roswell Park Comprehensive Cancer Center, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Penn State Milton S. Hershey Medical Center, Vanderbilt University, Cyclacel Pharmaceuticals (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2565304527